ICMR’s nationwide lab network strengthens outbreak surveillance, detects deadly viruses early, and fortifies the country’s ...

Even previously healthy children can become seriously ill with flu, the Royal College of Paediatrics and Child Health (RCPCH) ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

The median concentration across all sites in October 2025 was 17.1k copies/gram (cp/g), a decrease of ~74% compared to ...

Leading virologists fear a bad flu outbreak could leave people vulnerable to other seasonal illnesses at the same time, such ...

“The most common point that will generally contain germs are called ‘high-touch areas,’” said Kevin W. Garey, professor and ...

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...

A recent Indian Council of Medical Research (ICMR) study made some shocking revelations. It discovered that one in nine ...

Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. , a clinical-stage biotechnology company developing ...

As the air turns colder, wintertime illnesses are beginning to spread. In recent weeks, both Riverview Health and Eskenazi ...